U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526714) titled 'Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies' on March 26.
Brief Summary: Primary immunodeficiencies (PIDs) are a heterogeneous group of inborn errors of immunity characterized not only by increased susceptibility to infections but also by immune dysregulation. Among immune dysregulation manifestations, lymphoproliferative disorders represent a frequent and clinically challenging complication. These manifestations may involve secondary lymphoid organs (lymphadenopathy, splenomegaly) as well as extranodal organs such as lungs, liver, and gastrointestinal tract, often with lymphocytic and...